With a friendly Fed, a tight labor market and data like March retail sales, the chances for upside surprises are good.
Especially when healthcare CEOs discus political issues with analysts and reporters.
Here's your very own bank earnings 'cheat sheet.'
While Zoom has a lot going for it, its shares are now pricing in a lot of future growth. Relatively speaking, Pinterest doesn't look as expensive.
The current picture of mixed action for a market still very close to its all-time highs is something to watch.
CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.
These stocks are too hot. There's just not enough money chasing hotness.
Pinterest isn't exactly bringing the power to the people.
For investors interested in biotech, there's a lot to choose from, with options ranging from startups with potentially blockbuster new treatments to companies those that have been around the block a few times.
The company is a total ROI story, but can it share positive returns with IPO investors?